RxDoctor Payments Data

Marc Hoffmeister, PA

Physician Assistant · Cherryvale, KSNPI 1003815119

Payments from drug & device makers

$1,033in general payments, 2019–2025

Across 62 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$393
  • Lilly USA, LLC$177
  • Bayer$121
  • Axsome Therapeutics, Inc.$77
  • AstraZeneca$58
  • AbbVie$50
  • plus $157 from 9 others

What the payments were for

  • Food & beverage$1,033100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,033 in reported general payments places this provider in the 70th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$5,004
Medicare patients
54
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban291$157,047
MounjaroTirzepatide117$142,690
OzempicSemaglutide92$104,545
JardianceEmpagliflozin161$102,235
Tresiba Flextouch U-200Insulin Degludec142$98,258
FarxigaDapagliflozin Propanediol115$97,835
XareltoRivaroxaban78$65,610
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$55,463
Breztri AerosphereBudesonide/Glycopyr/Formoterol58$45,465
RexultiBrexpiprazole46$42,969
VraylarCariprazine Hcl38$36,502
Repatha SureclickEvolocumab56$31,213
Soliqua 100-33Insulin Glargine/Lixisenatide28$27,213
TrulicityDulaglutide19$24,708
MyrbetriqMirabegron46$24,320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$177$167,398136 claims
AstraZenecaFarxiga, Breztri Aerosphere$58$143,300173 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$21$89,763131 claims
AbbVieVraylar, Viberzi$50$57,76151 claims
Otsuka America Pharmaceutical, Inc.Rexulti$393$42,96946 claims
Axsome Therapeutics, Inc.Sunosi$77$10,61212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Cherryvale

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →